Emererthre's company has a hundred million dollar joint venture with bar crop science to engineer microbes to produce fertilizer for crops. Emererthre: It isn't an issue of, like, of, like, safety. It's an issue of trust, right? Like, thre's powerful technology being deployed. Do you trust the people deploying it to be acting in your interests? And when you frame it that way, well, what's one of the best ways to eliminate trust is to be like, yeh. I want to know, is this an my food caus i'm going to eat idn give j yu e yu kno?"
First Jason explains how to deliver great investor updates & the benefits of doing them well (1:36). Then, Ginkgo Bioworks CEO Jason Kelly joins to discuss the expanding capabilities of synthetic biology (24:48), how Ginkgo is currently helping customers make products more effectively (35:58), the ethics & risks of editing DNA (51:53) & more!